Search

everythinglearnresearchcommunity

for

Search:↓

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Washing can prevent cancer from lubricating oils, extreme body temperatures need more study, Sulfomid is not recognized, no reliable diphtheria carrier treatment except surgery, eyelid injuries should heal before repair, heterophile antibody test is specific for mononucleosis, chlorine inhalations for colds are outdated, and wheat germ is safe.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

New psoriasis treatments are effective but come with side effects and risks.

Cancer treatments often cause skin, nail, and hair problems.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Cedrol may help treat inflammatory bowel disease by improving gut health and function.

Erianin may effectively treat alopecia areata by targeting the immune system.

Exosomes from special stem cells help treat ulcerative colitis by reducing inflammation and stress.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Composite biomaterials can precisely control immune responses for better disease treatment.

Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Melatonin may help treat PCOS symptoms in rats.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Vaccination is the most effective way to reduce COVID-19 transmission.